Watch LG Household & Healthcare for free: we tell you when fair value or trend changes.

LG Household & Healthcare (051900) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of LG Household & Healthcare stock KRW 197,812, price KRW 234,000, that is 15.5% below the price, quality 58 out of 100. Rating: overvalued. Calculated from audited financials with 14 of our 26 valuation models and 37 quality factors, updated daily.

14 models, one by oneBear 148,303 KRW to bull 247,322 KRW Growth analysisrevenue history, year by year Quality 58/100 in detail37 factors, each one shown Compared with its peersrank on every measure, side by side

Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Consumer Defensive KR · ISIN KR7051900009

Some data Nov 6, 2026

LG Household & Healthcare

051900 · KO

Solid, but expensive

Our calculation puts a fair price 15% below what the stock costs today.

Low debt

Generates free cash flow

1.1% dividend yield · Cash covered

Profit last quarter +84% vs. a year ago.

Quality 58/100

Some data

Fair value 197,812 KRW · Overvalued (−15.5%)

Weak Growth (revenue 3y −4.0 %/yr in KRW)

Loss-making · -1.2% net margin (TTM)

Trails peers (5/14)

Narrow moat 26/100 · thin data

Watch LG Household & Healthcare for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

White line = price, green steps = our fair value per fiscal year. As of Nov 6, 2026.

How to read this chart

60‑month range 213,973 KRW – 1,323,293 KRW · fair‑value band 148,303 KRW – 247,322 KRW · the 234,000 KRW price screens above the 197,812 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 6, 2026.

Follow LG Household & Healthcare in your weekly email

Every Wednesday you see whether LG Household & Healthcare is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

LG H&H Co., Ltd. operates as cosmetics, household goods, and beverage company in South Korea and internationally.

Show moreShow less

The company offers cosmetics under The History of Whoo, O HUI, SU:M37, belif, ISA KNOX, Sooryehan, CODE GLOKOLOR, VONIN, CAREZONE, The Saga of Xiu, BEYOND, CNP, CNP Rx, VDL, VDIVOV, Nature Collection, THEFACESHOP, fmgt, DR.Belmeur, Yehwadam, and BEAUTE brands; toothpaste, toothbrush, mouthwash, and whitening products under the Perioe, Bamboosalt, and REACH brands; hair care products, including shampoo, conditioner, and hair treatment products under the Elastine, Organist, ReEn, Dr. Groot, and Silk Therapy brands; and skin and body care products under the Veilment and Physiogel Hypoallergenic brands.

It also provides fabric softeners under the Saffron, Saffron AURA, and Saffron Care brands; housekeeping solutions, such as baking soda, sodium percarbonate, and citric acid under the Han. Ip; detergent under the Pongpong, SAFE, TECH, SuperTie, and FiJi brands; bleach under the Oxygen Clean brand; home cleaning products under the Homestar brand; dishwashing under the Jayeonpong brand; fragrance under the Aura brand; baby care products under the Babience and method brands; pet care products under the Sirius brand; gift sets; and mini travel kits under the MINIS brand.

In addition, the company offers sparking and bottled water, juices, tea and coffee, sports and energy drinks, and lifestyle beverages under the Coca-Cola, Coke Zero, Coca-Cola light, Fanta, SPRITE, SPRITE KINCIDER, SCHWEPPES, Dr.Pepper, CANADA DRY, Seagram's, Crushed pear cider, Minute Maid, Minute Maid Qoo, Minute Maid Joy, Sunkist, Gwailchon, Cocoplam, Crushed Pear, Bong Bong, GEORGIA, Mate Tea of the Sun, Secret W, Real Leaf, POWERADE, TORETA, Monster Energy, Guronsan, ViO DIAMOND, ViO DIAMOND EC, ViO Soonsoo, Pyeongchang Water, GLACEAU vitamin water, and GO:GOOD brands.

It operates through stores. LG H&H Co., Ltd. was founded in 1947 and is headquartered in Seoul, South Korea.

Stock analysis

LG Household & Healthcare (051900) currently trades at 234,000 KRW, while our model-based Fair Value estimate is 197,812 KRW, 15% below the price, so the stock looks overvalued today.

Valuation

Bull case: the DCF Models group reads highest at a median of 406,746 KRW per share, and 8 of the 14 models we run sit above the 234,000 KRW price.

Bear case: the Asset-Based group reads lowest at 82,913 KRW, and 6 of the 14 models stay below the price. Data coverage for this calculation is medium.

Scenario range: 148,303 KRW (bear) to 247,322 KRW (bull), the price of 234,000 KRW sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 58/100 (solid quality), in the Consumer Defensive sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

LG Household & Healthcare reported revenue of 6.4T KRW in FY2025 versus 8.1T KRW in FY2021, a compound −5.9%/yr. Reported net income was −100B KRW in FY2025.

Key figures

Market cap 3.9T KRW (≈ $2.9B) Mid · P/S ratio 0.62 · EPS (TTM) −4,948 KRW · Dividend yield 1.1% · Net margin −1.2% · Return on equity −1.1% · Return on assets (EBIT) 8.5% (5-year average) · Operating margin 6.2%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 26 out of 100 (low confidence).

What moves the price

The share trades about 29% below its 52-week high and 9% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Consumer Defensive peers we cover trades at −26% fair-value upside, at −15%, 051900 screens cheaper than that median.

Fair Value models

Bear 148,303 KRW Fair Value 197,812 KRW Bull 247,322 KRW

Price 234,000 KRW · Downside -15.5%

Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.

Best data coverage

FCF DCF 348,970 KRW 503,391 KRW 736,071 KRW 80

Growth DCF 352,276 KRW 486,911 KRW 676,442 KRW 79

Owner Earnings 169,391 KRW 222,974 KRW 303,712 KRW 77

All 14 models by family

DCF Models

FCF DCF 348,970 KRW 503,391 KRW 736,071 KRW 80

Owner Earnings 169,391 KRW 222,974 KRW 303,712 KRW 77

5Y Revenue Exit 236,835 KRW 307,641 KRW 394,860 KRW 74

5Y EBITDA Exit 328,846 KRW 481,807 KRW 660,263 KRW 75

10Y Revenue Exit 272,337 KRW 346,840 KRW 442,462 KRW 68

10Y EBITDA Exit 333,542 KRW 466,652 KRW 644,095 KRW 69

Earnings-Based

EPV 127,680 KRW 136,302 KRW 143,773 KRW 74

Multiples

EV/EBIT 148,303 KRW 197,812 KRW 247,322 KRW 66

EV/EBITDA 272,973 KRW 364,039 KRW 455,105 KRW 67

EV/Revenue 105,783 KRW 151,215 KRW 196,647 KRW 53

Asset-Based

NCAV (Graham) 54,722 KRW 82,913 KRW 103,641 KRW 54

Growth DCF

Growth DCF 352,276 KRW 486,911 KRW 676,442 KRW 79

Rev-Margin DCF 236,835 KRW 310,764 KRW 398,327 KRW 74

Economic Profit

ROIC Compounder 127,680 KRW 136,302 KRW 143,773 KRW 72

Open the full fair value analysis →

Quality Score breakdown

Overall quality 58/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 36

How much profit the company makes from its sales and capital

Quality Growth 17

Are margins and returns getting better?

Cashflow 48

Do the profits arrive as real cash?

Financial strength 82

Debt, balance sheet and risk of trouble

Investment 99

Does it invest with discipline instead of growing at any price?

Low Volatility 62

How calm the share price moves, does not count

Price momentum 28

Price momentum of the last 3 to 12 months, does not count

Near the 52-week high 15

Distance to the 52-week high, does not count

New shares 82

Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 40/100

Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Revenue growth 1 year

−6.7%

Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

−4.0%

Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+7.5%

Start year 2020 (pandemic). Over 10 years: +1.8% a year

Revenue growth 23 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+7.7%

’14

’15

’16

’17

’18

’19

’20

’21

’22

’23

’24

’25

Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.

17.8% (2020) → 2.7% (2025)

What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss

not computed

Growth Forecast

Little optimism in the price

The price assumes less growth than the company has delivered so far and less than analysts expect.

What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).

−10.6%

The company could shrink this much every year for the next five years and today's price would still be justified.

What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.

+2.4%

Yearly sales growth analysts expect, extended to five years.

After inflation (South Korea: IMF forecast 2.1% a year to 2030, 2.1% from 2016 to 2025) that is about −12.5% a year for the price and +0.3% for the forecasts.

Forecast 2026 (sales)−0.9%

Forecast 2027 (sales)+3.5%

Projected 2028 (sales)+3.3%

Projected 2029 (sales)+3.1%

Projected 2030 (sales)+2.9%

051900 screens overvalued: fair value 15% below the price. Compare with Colgate-Palmolive Company →

Compare LG Household & Healthcare with another stock

Price, fair value, quality and upside side by side.

First stock

Second stock

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Household & Personal Products · 230 stocks

Beats the industry median on 4/12 measures

Overall it trails its industry peers.

Valuation

Quality Score 58 · Below median

Fair Value upside −15.5% · Below median

Profitability

Return on assets −1.5% · Bottom 25%

Net margin (12 months) −1.2% · Bottom 25%

Operating margin (12 months) 6.2% · Below median

Growth and dividend

Revenue growth (quarter YoY) 3.3% · Below median

Dividend yield (12 months) 1.1% · Bottom 25%

Valuation Multiplesvs Household & Personal Products median · lower = cheaper

P/B 0.72× · Cheapest 25%

P/S (12 months) 0.62× · Cheaper than median

Price / free cash flow (fiscal year) 11.2× · Cheaper than median

EV/EBITDA 6.8× · Cheaper than median

PEG 4.44× · Priciest 25%

Strength profile in five axes (Snowflake)

This stock

Sector peers

VALUE (fair-value potential)13 · sector 36

FUTURE (revenue growth)17 · sector 20

PAST (return on equity)0 · sector 31

HEALTH (low debt)100 · sector 98

DIVIDEND (yield)21 · sector 53

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate.

Stock	Price	Fair Value	vs Fair Value	Compare
Godrej Consumer Products Limited GODREJCP	₹851.00	₹1,146	+35%	vs 051900
Puig Brands, S.A PUIG	€19.84	€24.28	+22%	vs 051900
Henkel AG HEN	€74.85	€82.55	+10%	vs 051900
Beiersdorf Aktiengesellschaft, BEI	€85.26	€69.09	−19%	vs 051900
The Clorox Company CLX	$99.96	$74.29	−26%	vs 051900
Church & Dwight Co CHD	$109.33	$65.04	−41%	vs 051900
Colgate-Palmolive Company CL	$96.56	$56.16	−42%	vs 051900
Marico Limited MARICO	₹897.75	₹493.84	−45%	vs 051900
The Estée Lauder Companies Inc EL	$110.06	$44.21	−60%	vs 051900
Hindustan Unilever Limited HINDUNILVR	₹1,998	₹775.25	−61%	vs 051900

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued High-Quality Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks Undervalued Dividend Stocks Undervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Evidence & backtest34 years, failed companies included Financial calculatorsDCF, Graham, PEG and more

Run the numbers yourself: free valuation calculators

DCF Calculator P/E Ratio Calculator PEG Ratio Calculator Graham Number Peter Lynch Formula DDM Calculator Intrinsic Value Intrinsic vs Extrinsic Value P/E Ratio by Sector

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

LG Household & Healthcare: fair value per Fair Value Calculator

<a href="https://www.fairvalue-calculator.com/stock/051900?utm_source=embed&amp;utm_medium=badge" target="_blank" rel="nofollow noopener"><img src="https://www.fairvalue-calculator.com/embed/051900.KO.svg" width="360" height="84" alt="LG Household &amp; Healthcare: fair value per Fair Value Calculator" style="border:0;max-width:100%" loading="lazy"></a>

Cite: Fair Value Calculator (2026). "LG Household & Healthcare Fair Value". https://www.fairvalue-calculator.com/stock/051900

Frequently asked questions

Is LG Household & Healthcare (051900) overvalued or undervalued?

As of Nov 6, 2026, our model estimates a fair value of 197,812 KRW versus a price of 234,000 KRW, about 15% lower (overvalued).

What is the fair value of 051900?

Our model-based fair value for LG Household & Healthcare is 197,812 KRW (as of Nov 6, 2026), built from audited fundamentals. The current price: 234,000 KRW.

What is the quality score of 051900?

LG Household & Healthcare has a Quality Score of 58/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.

What is the price target for LG Household & Healthcare (051900)?

Our model-based price target is the fair value of 197,812 KRW (as of Nov 6, 2026) from 14 valuation models. Cautious scenario 148,303 KRW, optimistic scenario 247,322 KRW. It is a calculation from audited fundamentals, not an analyst target.

What is the LG Household & Healthcare stock forecast for 2026?

Our models put fair value at 197,812 KRW, about 15% lower versus a price of 234,000 KRW (overvalued). Cautious scenario 148,303 KRW, optimistic scenario 247,322 KRW. The calculation is refreshed regularly with new filings.

What is the revenue of LG Household & Healthcare (051900)?

LG Household & Healthcare reported trailing-twelve-month revenue of about 6.3T KRW (latest available figure, as of Nov 6, 2026).

Does LG Household & Healthcare pay a dividend?

LG Household & Healthcare currently shows a dividend yield of 1.07% relative to its recent price (as of Nov 6, 2026).

How much is the dividend of LG Household & Healthcare (051900) and when is the ex-dividend date?

LG Household & Healthcare pays a dividend of 2,500 KRW per share a year, a dividend yield of 1.1%. The last ex-dividend date was Aug 13, 2026. Free cash flow covers the dividend 9.60 times. Our assessment: Cash covered. The dividend is fully funded by free cash flow. The payout ratio on earnings is not available for this company.

What growth is priced into LG Household & Healthcare (051900)?

For today's price to be fair in a discounted-cash-flow model, LG Household & Healthcare would have to grow free cash flow by -10.6 % per year for five years (discount rate 9.3 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +7.5 % per year. As of Nov 6, 2026.

What discount rate (WACC) does the fair value of 051900 use?

Our models discount LG Household & Healthcare at 9.3 %: a base by market capitalisation (mid), damped by beta 0.69, country premium for South Korea. The same rate applies in all 26 models.

What is a reverse DCF?

A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For LG Household & Healthcare that is -10.6 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (9.3 %) and the same formula as our fair value.

How much growth has LG Household & Healthcare (051900) delivered so far?

Over the past 5 years revenue at LG Household & Healthcare grew +7.5 % a year. The price currently implies free-cash-flow growth of -10.6 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.

How fast is the sector of LG Household & Healthcare (051900) growing?

The median revenue growth in the sector is +3.6 % a year. That is the yardstick for the growth priced into LG Household & Healthcare (-10.6 % per year): it shows whether the expectation is within the usual range or beyond it.

What is the free cash flow yield of LG Household & Healthcare (051900)?

The free-cash-flow yield on the price is 10.26 %: that much free cash flow LG Household & Healthcare produces per unit of market value. When it exceeds the discount rate of our models (9.3 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.

What is the intrinsic value of LG Household & Healthcare (051900)?

Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For LG Household & Healthcare it is 197,812 KRW per share (as of Nov 6, 2026), against a price of 234,000 KRW. It is the blended result of 14 valuation models in 6 families (DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit).

Is LG Household & Healthcare stock overvalued or undervalued in 2026?

As of Nov 6, 2026, 051900 trades above its calculated fair value: price 234,000 KRW, fair value 197,812 KRW, a gap of about −15% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.

Is fair value the same as the market price of 051900?

No. The price is what the market pays today (234,000 KRW); the fair value is what the company's own numbers justify (197,812 KRW). For LG Household & Healthcare the two are 36,188 KRW per share apart. That gap is exactly why we show both numbers side by side.

How much is LG Household & Healthcare worth?

The market values LG Household & Healthcare at about 3.9T KRW (market capitalisation, as of Nov 6, 2026). Per share that is 234,000 KRW; our models calculate a fair value of 197,812 KRW per share.

What do the bullish and bearish scenarios say about 051900?

Our models span a range for LG Household & Healthcare: cautious scenario 148,303 KRW, base 197,812 KRW, optimistic 247,322 KRW per share (as of Nov 6, 2026, price 234,000 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.

What is the PEG ratio of 051900?

The PEG ratio of LG Household & Healthcare is 4.44 (P/E divided by earnings growth, as of Nov 6, 2026). That is above 1, so the growth is already paid for in the price.

How solid is the balance sheet of LG Household & Healthcare (051900)?

Balance-sheet figures for LG Household & Healthcare (as of Nov 6, 2026): return on equity −1.1%. They feed the Quality Score of 58/100, which measures business quality independently of the share price.

How far is 051900 from its 52-week high?

LG Household & Healthcare trades at 234,000 KRW, about 29% below its 52-week high of 331,907 KRW and 9% above the low of 213,973 KRW (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 197,812 KRW is for.

Which stocks are comparable to LG Household & Healthcare?

From the same area (Consumer Defensive) we also value Colgate-Palmolive Company, Hindustan Unilever Limited, The Estée Lauder Companies Inc, Henkel AG, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.

Is LG Household & Healthcare stock attractive at the current price?

The data as of Nov 6, 2026: price 234,000 KRW, calculated fair value 197,812 KRW (−15%), Quality Score 58/100, from 14 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.

How is the fair value of 051900 calculated?

We run LG Household & Healthcare through 14 models from 6 families: DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit. Every model gets the same audited fundamentals; the fair value of 197,812 KRW builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.

Is it still worth investing in stocks now?

The global stock market currently sits 13.0% above its aggregate fair value. LG Household & Healthcare itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.

What is the share price of LG Household & Healthcare (051900)?

The closing price on Nov 6, 2026 was 234,000 KRW. Our model-based fair value is 197,812 KRW, about 15% lower (overvalued). We carry closing prices from our data provider, not a live tick.

What should I pay attention to with LG Household & Healthcare right now?

Solid but not exceptional quality (58/100) and above fair value, neither a clear bargain nor a standout compounder. The price sits in the upper half of our model range, so the margin of safety is thin. Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.

Key figures of LG Household & Healthcare

How large is the market capitalisation of LG Household & Healthcare (051900)?

The market capitalisation of LG Household & Healthcare is 3.9T KRW (≈ $2.9B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.

What is the P/S ratio of LG Household & Healthcare (051900)?

The price-to-sales ratio of LG Household & Healthcare is 0.62 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.

What are the earnings per share of LG Household & Healthcare (051900)?

Earnings per share at LG Household & Healthcare are −4,948 KRW. Earnings per share over the last twelve months: total profit spread across every single share.

What is the dividend yield of LG Household & Healthcare (051900)?

The dividend yield of LG Household & Healthcare is 1.1%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.

What is the net margin of LG Household & Healthcare (051900)?

The net margin of LG Household & Healthcare is −1.2% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.

What is the return on equity of LG Household & Healthcare (051900)?

The return on equity (ROE) of LG Household & Healthcare is −1.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.

What is the EBIT return on assets of LG Household & Healthcare (051900)?

On an EBIT basis the return on assets of LG Household & Healthcare is 8.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.

What is the operating margin of LG Household & Healthcare (051900)?

The operating margin of LG Household & Healthcare is 6.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.

How fast is revenue growing at LG Household & Healthcare (051900)?

Revenue at LG Household & Healthcare is growing +3.3% versus a year earlier (3y avg −4.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.

How fast are earnings growing at LG Household & Healthcare (051900)?

Earnings per share at LG Household & Healthcare are growing +83.7% versus a year earlier. How much earnings per share grew versus a year earlier.

How much net debt does LG Household & Healthcare (051900) carry?

The net debt of LG Household & Healthcare is 3.3B KRW (fiscal year 2020, ≈ 0.0 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.

Free · no account needed

Watch LG Household & Healthcare in the live analysis

One click puts LG Household & Healthcare on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.